In case you missed it, some of this week’s featured content includes a new podcast episode, a video series on the COVID-19 vaccine and dermal fillers, topical PRP, expansion of the CoolSculpting portfolio, combination therapies as the future of rosacea treatment, plus more.
This week’s edition of The Mainstream Patient features stories on skin icing, TikTok skinfluencers and their impact on the beauty industry, skin picking, blister care, plus more.
In this expert interview, Whitney Bowe, MD, explains the rare adverse reactions the medical community has recently been seeing in dermal filler patients who received the COVID-19 vaccine.
In the second part of our interview with Whitney Bowe, MD, she reveals the type of fillers that have been linked to adverse reactions in dermal filler patients who have received the COVID-19 vaccine.
Results of a recent in vitro study show that a novel topical cosmetic vehicle successfully stabilizes and preserves platelet-rich plasma (PRP).
Galderma announced the launch of its Face for Change program that allows abobotulinumtoxinA (Dysport) patients to give back with each treatment received to either Dress for Success or The Skin Cancer Foundation.
In part 3, Whitney Bowe, MD, suggests how physicians should manage their patients' expectations when it comes to HA fillers and the COVID-19 vaccine.
Allergan Aesthetics plans on expanding its CoolSculpting portfolio with the launch of its novel CoolSculpting Elite device that targets visible fat in nine different areas of the body.
A recent study found states' Medicare per-beneficiary spending between actinic keratosis and skin cancer differs widely.
Recent reports have been surfacing in regard to adverse reactions in dermal fillers patients who have also received the COVID-19 vaccine. Whitney Bowe, MD, New York City, New York, discusses this phenomenon and provides some tips for preventing and treating these side effects.
In part 4 of our interview with Whitney Bowe, MD, she dives into the multiple methods physicians can use to treat adverse reactions from the COVID-19 vaccine in their dermal filler patients.
Safety profiles remain consistent longer-term but cost and accessibility are major challenges for biologics aimed at treating psoriasis.
Candela announces the launch of its Frax Pro system, featuring dual-depth skin resurfacing with both novel Frax 1940 and Frax 1550 applicators.
In the final part of our interview with Whitney Bowe, MD, she reveals her tips and tricks for both preventing and minimizing any adverse reactions in her filler patients who might have also received the COVID-19 vaccine.
Experts are recommending combination therapies as a way to treat rosacea, according to a presentation at ODAC Dermatology, Aesthetic and Surgical Conference 2021 Pre-Conference Sneak Peek Inflammatory Diseases Virtual Symposium.